SCHEMBL336958

SCHEMBL336958

CCCCCCCCC(=O)Oc1ccc2c(C)cc(=O)oc2c1

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 13/20 0.84
KDM4E B2RXH2 10/20 0.84
GLA P06280 6/20 0.84
KMT2A Q03164 6/20 0.84
GAA P10253 6/20 0.84
HPGD P15428 6/20 0.69
MAPT P10636 4/20 0.69
MEN1 O00255 2/20 0.69
LMNA P02545 2/20 0.69
HSD17B10 Q99714 2/20 0.57
NPBWR1 P48145 1/20 0.57
AR P10275 2/20 0.55
F2 P00734 1/20 0.55
SMN1; SMN2 Q16637 3/20 0.55
NPC1 O15118 1/20 0.55
CASP3 P42574 1/20 0.55
RAB9A P51151 1/20 0.55
SENP8 Q96LD8 1/20 0.55
SENP7 Q9BQF6 1/20 0.55
SENP6 Q9GZR1 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1095310 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL381723 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL28985589 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL29466589 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL381035 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL3219473 1.00 ALDH1A1 (0.84) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL28590565 0.99 ALDH1A1 (0.86) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL17275251 0.94 ALDH1A1 (0.75) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL233650 0.94 ALDH1A1 (0.73) ALDH1A1KDM4EGLAKMT2AGAA
SCHEMBL13171966 0.94 ALDH1A1 (0.73) ALDH1A1KDM4EGLAKMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250207175-A1 METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-06-26 US claimed
EP-4490518-A1 METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-01-15 EP claimed
CN-118901012-A Method for detecting contaminating carboxylesterase activity 勃林格殷格翰国际公司 2024-11-05 CN claimed
US-20240271180-A1 METHOD FOR DETECTING CONTAMINATING LIPASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2024-08-15 US claimed
WO-2023170139-A1 METHOD FOR DETECTING CONTAMINATING CARBOXYLESTERASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-09-14 WO claimed
EP-4211256-A1 METHOD FOR DETECTING CONTAMINATING LIPASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-07-19 EP claimed
CN-116457470-A Method for detecting contaminating lipase activity 勃林格殷格翰国际公司 2023-07-18 CN claimed
WO-2022049294-A1 METHOD FOR DETECTING CONTAMINATING LIPASE ACTIVITY BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2022-03-10 WO claimed
US-8097404-B2 Composition and method for cell permeabilization comprising N-octyl-β-D-glucopyranoside, sodium polyphosphates, rubidium chloride and/or lithium chloride for detecting living cells on a membrane MILLIPORE CORPORATION (US) 2012-01-17 US claimed
EP-2107119-B1 Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane MILLIPORE CORP (US) 2010-05-12 EP claimed
EP-2107119-A1 Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane Millipore Corporation (US) 2009-10-07 EP claimed
US-20090246822-A1 Composition for cell permeabilization comprising NOG, HMP, rubidium chloride and/or lithium chloride for detecting living cells on a membrane EMD MILLIPORE CORPORATION 2009-10-01 US claimed
US-4868110-A Methods and device for detection of microorganisms BIOCONTROL SYSTEMS, INC. (US) 1989-09-19 US claimed
EP-0091837-B1 MICROBIOLOGICAL TEST PROCESSES AND APPARATUS RADIOMETER CORPORATE DEVELOPMENT LIMITED (GB) 1989-07-26 EP claimed
EP-0264221-A2 Methods and device for detection of microorganisms BioControl Systems, Inc. (US) 1988-04-20 EP claimed
US-20260036584-A1 COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE THE BOARD OF SUPERVISORS OF LOUISIANA STATE UNIV AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2026-02-05 US disclosed
WO-2025262318-A1 MULTI-HYDROLASE KNOCKOUT BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2025-12-26 WO disclosed
EP-0264221-A2 Methods and device for detection of microorganisms BioControl Systems, Inc. (US) 1988-04-20 EP disclosed
WO-1983003624-A1 MICROBIOLOGICAL TEST PROCESSES AND APPARATUS UNILEVER PLC (GB) 1983-10-27 WO disclosed
EP-0091837-A1 Microbiological test processes and apparatus RADIOMETER CORPORATE DEVELOPMENT LIMITED (GB) 1983-10-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260036584-A1 COMPOSITIONS AND METHODS TO DETECT GASTROINTESTINAL DISEASE SI, FABP2, VIP ALDH1A1 4642/4885KDM4E 4490/4885GLA 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.